相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies
Polychronis Pavlidis et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Autoreactivity to isoforms of glycoprotein 2 in inflammatory bowel disease
Dirk Roggenbuck et al.
CLINICA CHIMICA ACTA (2015)
Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease
Maike Anna Michaels et al.
INFLAMMATORY BOWEL DISEASES (2015)
Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]
Maria Papp et al.
JOURNAL OF CROHNS & COLITIS (2015)
Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation Rate
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch
Polychronis Pavlidis et al.
Journal of Crohns & Colitis (2013)
Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch
Lael Werner et al.
Journal of Crohns & Colitis (2013)
The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease
Valentina Somma et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease
Dimitrios P. Bogdanos et al.
BMC GASTROENTEROLOGY (2012)
Ileal InflammationMay Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn's Disease
Polychronis Pavlidis et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies
Dimitrios P. Bogdanos et al.
AUTOIMMUNITY REVIEWS (2011)
Antibodies to glycoprotein 2 (GP2) in patients with inflammatory bowel diseases from UK
Polychronis Pavlidis et al.
CLINICA CHIMICA ACTA (2011)
Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease
Dirk Roggenbuck et al.
CLINICA CHIMICA ACTA (2011)
Standardized detection of anti-ds DNA antibodies by indirect immunofluorescence - A new age for confirmatory tests in SLE diagnostics
Dirk Roggenbuck et al.
CLINICA CHIMICA ACTA (2011)
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
Kelvin T. Thia et al.
GASTROENTEROLOGY (2010)
Association of the Novel Serologic Anti-glycan Antibodies Anti-laminarin and Anti-chitin with Complicated Crohn's Disease Behavior
Florian Rieder et al.
INFLAMMATORY BOWEL DISEASES (2010)
Serum Anti-Glycan Antibodies Predict Complicated Crohn's Disease Behavior: A Cohort Study
Florian Rieder et al.
INFLAMMATORY BOWEL DISEASES (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Presence of Anti-Microbial Antibodies in Liver Cirrhosis - A Tell-Tale Sign of Compromised Immunity?
Maria Papp et al.
PLOS ONE (2010)
Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease
D. Roggenbuck et al.
GUT (2009)
Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response
Koji Hase et al.
NATURE (2009)
New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort
Maria Papp et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD
Shane M. Devlin et al.
INFLAMMATORY BOWEL DISEASES (2008)
Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis
Wahiba Sakly et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
Marc Ferrante et al.
GUT (2007)
Pancreatic autoantibodies in Greek patients with inflammatory bowel disease
IE Koutroubakis et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease
SR Targan et al.
GASTROENTEROLOGY (2005)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Association of antibodies to exocrine pancreas with subtypes of Crohn's disease
FH Klebl et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease
WS Mow et al.
GASTROENTEROLOGY (2004)
Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens
CJ Landers et al.
GASTROENTEROLOGY (2002)
Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability:: A study in IBD families
S Vermeire et al.
INFLAMMATORY BOWEL DISEASES (2001)
Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics
EA Vasiliauskas et al.
GUT (2000)
Identification of a novel bacterial sequence associated with Crohn's disease
CL Sutton et al.
GASTROENTEROLOGY (2000)